News

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.
The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...
One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...
Less regulation was also the focus of committee chair Rep. James Comer (R-Ky.). "The Biden administration stifled innovation ...
In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court ...
U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as sources say recent layoffs have had ...
The US FDA is coping with a series of Trump-imposed job cuts. These are starting to hamper food safety and pharmaceutical ...
FORT LAUDERDALE, FL / ACCESS Newswire / April 18, 2025 / EndoUVtech, a pioneering medical device company dedicated to transforming surgical stroke patient outcomes, today announced a crucial step in ...
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...
Artificial intelligence has become one of the most transformative forces in health care, reshaping everything from drug discovery to diagnostics.
"FDA FOIA staff, including those working on litigation involving CBER, were impacted as part of HHS' reorganization," Nixon ...